In MTX-treated cancer cells, KIRA6 inhibited NF-κB-driven transcription of several cytokines/chemokines, their chemoattractant and DC-maturation ability and significantly reduced the vaccination potential of MTX-treated cancer cells in syngeneic mice, without altering, if anything even increasing, DAMP exposure. Here, NFKB1 is linked to cancer.